CDK6/9-IN-2
CDK6/9-IN-2 is a highly active dual inhibitor of CDK6 (IC50 = 15 nM) and CDK9 (IC50 = 22 nM). CDK6/9-IN-2 is selective for CDK2, CDK8, and CDK11. CDK6/9-IN-2 inhibits the proliferation of HaCaT cells induced by IFN-γ/TNF-α and suppresses the STAT3 pathway and the expression of inflammatory factors. CDK6/9-IN-2 can alleviate psoriatic dermatitis and is useful in psoriasis research.
For research use only. We do not sell to patients.
- CAS No.: 3068529-24-5
- Formula: C25H30ClN7O
- Molecular Weight:480.01
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
|
CDK6 15 nM (IC50) |
CDK9 22 nM (IC50) |
STAT3 |
IL-6 |
IL-1β |
IL-8 |
CDK6/9-IN-2 (Compound 4) (0.0032-2 μM, 2 + 24 h) can effectively inhibit cell proliferation at 80 nM in IFN-γ/TNF-α induced HaCaT cells[1].
CDK6/9-IN-2 (0.1-1 μM, 24 h) inhibits the STAT3 pathway and the expression of inflammatory factors to improve inflammatory damage to skin cells in IFN-γ/TNF-α induced HaCaT cells[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:IFN-γ/TNF-α (2 ng/ml, 24 h) induced HaCaT cells
-
Concentration:0.1 μM, 0.4 μM, 1 μM,
-
Incubation Time:24 h
-
Result:Inhibited the phosphorylation of STAT3 and the secretion of various inflammatory factors (including IL-1β, IL-6 and IL-8).
-
Cell Line:IFN-γ/TNF-α (2 ng/ml, 24 h) induced HaCaT cells
-
Concentration:0.1 μM, 0.4 μM, 1 μM,
-
Incubation Time:24 h
-
Result:Inhibited IL-1β, IL-6 and IL-8 mRNA levels.
Chemical Information
-
CAS No. 3068529-24-5
-
Molecular Weight 480.01
-
Formula C25H30ClN7O
-
SMILES
CN1CCN(CC1)C2=CC=C(C=C2)NC3=NC=C(C(NC4=CC=C(C=C4)N5CC[C@@H](C5)O)=N3)Cl
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)